16-11838113-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015659.3(RSL1D1):āc.1147A>Gā(p.Ile383Val) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000128 in 1,556,952 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_015659.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000661 AC: 1AN: 151192Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000494 AC: 1AN: 202346Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 111278
GnomAD4 exome AF: 7.11e-7 AC: 1AN: 1405642Hom.: 0 Cov.: 30 AF XY: 0.00000144 AC XY: 1AN XY: 696224
GnomAD4 genome AF: 0.00000661 AC: 1AN: 151310Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 73920
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1147A>G (p.I383V) alteration is located in exon 9 (coding exon 9) of the RSL1D1 gene. This alteration results from a A to G substitution at nucleotide position 1147, causing the isoleucine (I) at amino acid position 383 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at